Cevimeline hydrochloride
- Level
- Commodity
- Parent
- 51151500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51151538This classification denotes a cholinergic agonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P81Q6V85NP. European Medicines Agency schedules Cevimeline hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01186MIG. Cevimeline hydrochloride generally arises in the molecular formula 2C10H17NOS.2CLH.H2O. The term 'cevimeline hydrochloride' is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule cevimeline hydrochloride under HS 29349990 and SITC 51579. As of Q4 2014, CEVIMELINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Cevimeline hydrochloride bears US NLM identifiers UMLS ID C0874063 and NCI Concept Code C1337. SMILES: C[C@H]1O[C@@]2(CN3CCC2CC3)CS1.C[C@H]1O[C@@]2(CN3CCC2CC3)CS1.O.CL.CL.
Same parent
Under 51151500 · 44Activities that produce or sell this
KBLI · 8Inherited from family 51150000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.